Clinical Trials Browser

Phase 2 × Not yet recruiting × vorolanib × Clear all

NCT06523049 2024-07-26

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

Phase 2 Not yet recruiting

Carcinoma, Renal Cell